AMY ANTLE: Open Payments
NPI 1831285477 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 20 payments from 7 companies in 2025. Trend: 2023 $330 · 2024 $325 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $213 |
| Ardelyx, Inc. | 3 | $67 |
| Madrigal Pharmaceuticals | 2 | $56 |
| QOL Medical, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: RINVOQ, IBSRELA, REZDIFFRA, Sucraid, OMVOH, VOQUEZNA, ZENPEP, LINZESS.
Industry payments across KY — which companies pay providers there.
